AdaptHealth director granted 18,999 RSUs

BELINFANTI GREGORY reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

BELINFANTI GREGORY reported acquisition or exercise transactions in this Form 4 filing.

AdaptHealth Corp. director Gregory Belinfanti received an equity grant in the form of restricted stock units. He was awarded 18,999 shares of common stock at no purchase price, increasing his direct holdings to 104,269 shares following the grant. The units will settle in common stock upon vesting.

Insider Trade Summary

Grant/Award: 18,999 shares

Grant/Award 1 txn

Insider BELINFANTI GREGORY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,999	$0.00	$0.00

Holdings After Transaction: Common Stock — 104,269 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Key Figures

RSUs granted: 18,999 shares Holdings after transaction: 104,269 shares Grant price per share: $0.00 per share +2 more

5 metrics

RSUs granted 18,999 shares Restricted stock units granted on 2026-06-24

Holdings after transaction 104,269 shares Total common stock directly held after grant

Grant price per share $0.00 per share Compensation-related award, not open-market purchase

Transaction code A Grant, award, or other acquisition of common stock

Transaction direction acquire Equity position increased via RSU grant

Key Terms

restricted stock units, Grant, award, or other acquisition, Common Stock, Form 4

4 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for Gregory Belinfanti?

AdaptHealth reported that director Gregory Belinfanti received a grant of 18,999 restricted stock units. These RSUs represent shares of common stock that will be delivered upon vesting, increasing his direct equity stake in the company.

How many AdaptHealth (AHCO) shares does Gregory Belinfanti hold after this Form 4?

After the reported grant, Gregory Belinfanti directly holds 104,269 shares of AdaptHealth common stock. This total includes the 18,999 restricted stock units awarded in the latest transaction, which will convert into shares when the vesting conditions are satisfied.

What type of securities were granted to Gregory Belinfanti at AdaptHealth (AHCO)?

Gregory Belinfanti received restricted stock units that will be settled in AdaptHealth common stock upon vesting. RSUs are a form of equity compensation that convert into shares over time, typically based on continued service or other vesting conditions.

Was there a purchase price for Gregory Belinfanti’s AdaptHealth (AHCO) equity grant?

The grant to Gregory Belinfanti carried a per-share transaction price of $0.00. This indicates it was a compensation-related award, not an open-market purchase, and reflects standard practice for director or executive equity grants in many public companies.

Does this AdaptHealth (AHCO) Form 4 show any stock sales by Gregory Belinfanti?

The filing does not report any stock sales by Gregory Belinfanti. It shows only an acquisition coded as a grant or award of 18,999 restricted stock units, which increases his overall direct ownership position in AdaptHealth common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:12 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BELINFANTI GREGORY

(Last) (First) (Middle)

C/O ONE EQUITY PARTNERS

510 MADISON AVENUE, 19TH FLOOR

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		18,999(1)	A	$0	104,269	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Gregory Belinfanti	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)